HIV Frontline : no.35(1998:Winter)
| dc.contributor.author | Ferri, Richard S. | |
| dc.contributor.author | Fontaine, Michele | |
| dc.contributor.author | Gallego, Susan M. | |
| dc.contributor.author | Lynch, Vincent J. | |
| dc.contributor.author | O'Brien, John G. | |
| dc.contributor.author | Perez, George | |
| dc.contributor.author | Sheran, Michael E. | |
| dc.contributor.author | Shiloh-Cryer, Angela | |
| dc.contributor.author | Zevin, Barry | |
| dc.contributor.other | World Health CME | |
| dc.date.accessioned | 2025-05-01T15:02:17Z | |
| dc.date.available | 2025-05-01T15:02:17Z | |
| dc.date.issued | 1998 | |
| dc.description.scopeandcontents | HIV Frontline is "a newsletter for professionals who counsel people living with HIV." The July-August 2000 issue delves into the complexities of initiating and managing antiretroviral therapy (ART) for people living with HIV. It explores the benefits and risks of early treatment, emphasizing the need for patient readiness and strict adherence to ensure long-term success. Key topics include strategies for minimizing resistance, addressing adherence barriers, and customizing treatment plans based on individual needs. The issue also reviews new ART regimens and highlights their advantages and challenges. Additionally, it covers complications associated with long-term ART, such as mitochondrial toxicity, lipodystrophy, and hepatotoxicity. The publication stresses the critical role of counselors in supporting clients through education, adherence strategies, and holistic care. | |
| dc.identifier.uri | https://hdl.handle.net/11244/341106 | |
| dc.relation.ispartofseries | HIV Frontline | |
| dc.rights | Contact UCO Chambers Library's Digital Initiatives Working Group at diwg@uco.edu for the permission policy on the use, reproduction or distribution of this material. | |
| dc.subject.homoit | HIV/AIDS | |
| dc.subject.homoit | Antiretroviral drugs | |
| dc.subject.homoit | HIV counseling | |
| dc.subject.homoit | Treatment adherence | |
| dc.subject.homoit | Drug resistance | |
| dc.subject.homoit | Lipodystrophy | |
| dc.subject.homoit | Public health | |
| dc.subject.homoit | Long-term ART effects | |
| dc.subject.homoit | HIV care strategies | |
| dc.subject.keywords | HIV treatment | |
| dc.subject.keywords | Antiretroviral therapy | |
| dc.subject.keywords | ART | |
| dc.subject.keywords | Adherence | |
| dc.subject.keywords | Drug resistance | |
| dc.subject.keywords | Mitochondrial toxicity | |
| dc.subject.keywords | Lipodystrophy | |
| dc.subject.keywords | Hepatotoxicity | |
| dc.subject.keywords | Counseling | |
| dc.subject.keywords | Treatment readiness | |
| dc.subject.keywords | HIV care | |
| dc.subject.keywords | Public health | |
| dc.subject.keywords | Long-term ART complications | |
| dc.subject.keywords | HIV advocacy | |
| dc.subject.keywords | Therapy strategies | |
| dc.title | HIV Frontline : no.35(1998:Winter) | |
| dc.type | Periodical |